A new series of β-aminochalcogenides were designed and synthesized to identify new carbonic anhydrase activator (CAA) agents as novel tools for the management of several neurodegenerative and metabolic disorders which represent a clinical challenge without effective therapies available. Some β-aminoselenides and β-aminotellurides showed effective CA activating effects and a potent antioxidant activity
设计并合成了一系列新的β-
氨基
硫属元素化物,以鉴定新的
碳酸酐酶激活剂(
CAA),作为治疗几种神经退行性和代谢性疾病的新工具,这代表了在没有有效治疗方法的情况下的临床挑战。一些β-
氨基
硒化物和β-
氨基
碲化物显示出有效的CA活化作用和有效的抗氧化活性。
CAA可用于记忆疗法和CA缺乏症候群。